Skip to content

CYPH CYPH Return on assets

Return on assets at other companies

Pfizer logo
PfizerPFE
4.6%
Merck & Co. logo
Merck & Co.MRK
7.3%-8.4pp
Amgen logo
AmgenAMGN
8.6%+2.1pp
MicroStrategy logo
MicroStrategyMSTR
19.3%+15.3pp
CNT
Canton Strategic Holdings, Inc. Common StockCNTN
-27.5%-12.9pp
Ziff Davis logo
Ziff DavisZD
1.3%-0.8pp

Other financials

Income statement

See full
Revenue$375.0K
Operating income-$4.8M+69.7%
Net income-$77.2M-400%
EPS (diluted)-$0.46-24.3%

Balance sheet

See full
Cash & equivalents$6.7M-79.6%
Total debt$38.0K-75.3%
Total equity$84.4M+305%
Total assets$87.4M+151%

Cash flow

See full
Operating cash flow-$3.4M+76.3%

Valuation

See full
Market cap$65.19M-54.5%
Enterprise value$58.54M
P/S43.5×

Profitability

See full
Operating margin-2,761.7%
Net margin-2,705.8%

Returns & leverage

See full
Return on equity-108.2%-34.4pp
Debt / equity0.0×
Current ratio27.3×+24.9×

Where this comes from

Calculated from CYPH’s reported figures.

Based on trailing twelve months.

The official record: CYPH’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CYPH's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CYPH's return on assets?
CYPH (CYPH) reported return on assets of -93.1% in Q1 2026.
How has CYPH's return on assets changed year-over-year?
CYPH's return on assets increased by 37.5% year-over-year, from -149% to -93.1%.
What is the long-term trend for CYPH's return on assets?
Over 2 years (2023 to 2025), CYPH's return on assets has grown at a -80.0% compound annual growth rate (CAGR), from -113.7% to 4.5%.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.